# Savolitinib

Precision Oncology Gains Ground in China: AmoyDx Secures Regulatory Nod for c-Met Lung Cancer Diagnostic

Amoy Diagnostics has received NMPA approval for its c-Met gene amplification kit, a companion diagnostic for the lung cancer drug Savolitinib. This development marks a vital step in China's push for localized precision oncology and sophisticated personalized medicine tools.